Vegf Inhibitors | List of Frontiers open access articles

Original Research

Published on 10 Nov 2022

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

in Pharmacoepidemiology

Takamasa Sakai
Chiyo Mori
Fumiko Ohtsu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1063625

5,981 views
16 citations

Case Report

Published on 18 Nov 2020

Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy

in Pituitary Endocrinology

Lydia S. Lamb
Hao-Wen Sim
Ann I. McCormack

Frontiers in Endocrinology

doi 10.3389/fendo.2020.576027

4,489 views
44 citations

Case Report

Published on 16 Jan 2026

Literature review of leukoencephalopathy with calcifications and cysts and a case report

in Translational Neuroscience

Chao Guan
Huanting Li
Zechen Wang
Jie Wu
Yunqing Chen
Yugong Feng
Zhenwen Cui
Chen Shen
Pin Guo

Frontiers in Neuroscience

doi 10.3389/fnins.2026.1686818

738 views

Review

Published on 14 May 2025

Insights into the mechanisms of angiogenesis in hepatoblastoma

in Cancer Cell Biology

Meng Kong
Yunpeng Zhai
Hongzhen Liu
Shisong Zhang
Shuai Chen
Wenfei Li
Xiang Ma
Yi Ji

Frontiers in Cell and Developmental Biology

doi 10.3389/fcell.2025.1535339

6,271 views
4 citations

Case Report

Accepted on 23 Feb 2026

Cervical yolk sac tumor: A case report and literature review

in Gynecological Oncology

Shuiqing Xu
Ming Wang
Yang Zhan
Bei Fan
Yumei Wu

Frontiers in Oncology

Mini Review

Published on 09 May 2019

Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors

in Vaccines and Molecular Therapeutics

Rodrigo Barbosa de Aguiar
Jane Zveiter de Moraes

Frontiers in Immunology

doi 10.3389/fimmu.2019.01023

10,595 views
68 citations

Systematic Review

Published on 14 Nov 2025

Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis

in Renal Pharmacology

Yu Zheng
Fan Zhang
Xueling Li
Xianwen Zhang
Yifei Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2025.1691597

1,487 views

Original Research

Published on 04 Aug 2023

Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination

in Advanced Methods in Pharmacovigilance and Pharmacoepidemiology

Takahiro Niimura
Mitsuhiro Goda
Koji Miyata
Jun Matsumoto
Toshihiko Yoshioka
Hirofumi Hamano
Fuka Aizawa
Kenta Yagi
Yuki Izawa-Ishizawa
Yoshito Zamami

Frontiers in Drug Safety and Regulation

doi 10.3389/fdsfr.2023.1213771

4,166 views
7 citations

Original Research

Published on 03 Jan 2022

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance

in Pharmacology of Anti-Cancer Drugs

Qingli Cui
Yanhui Hu
Qingan Cui
Daoyuan Wu
Yuefeng Mao
Dongyang Ma
Huaimin Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.746707

8,546 views
22 citations

Original Research

Published on 22 Oct 2024

Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models

in Cancer Immunity and Immunotherapy

Hongyu Kuang
Qingkai Yan
Zhanzhi Li
Anqi Lin
Kailai Li
Jian Zhang
Peng Luo
Yuehui Yin

Frontiers in Immunology

doi 10.3389/fimmu.2024.1488853

5,709 views
11 citations

Original Research

Published on 12 Mar 2020

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports

in Drugs Outcomes Research and Policies

Janet Sultana
Giulia Scondotto
Paola Maria Cutroneo
Francesca Morgante
Gianluca Trifirò

Frontiers in Pharmacology

doi 10.3389/fphar.2020.00315

8,304 views
34 citations

Articles

Potential safety signal of pregnancy loss with vascular endothelial growth factor inhibitor intraocular injection: A disproportionality analysis using the Food and Drug Administration Adverse Event Reporting System

Case Report: A Case of Pituitary Carcinoma Treated With Sequential Dual Immunotherapy and Vascular Endothelial Growth Factor Inhibition Therapy

Literature review of leukoencephalopathy with calcifications and cysts and a case report

Insights into the mechanisms of angiogenesis in hepatoblastoma

Cervical yolk sac tumor: A case report and literature review

Exploring the Immunological Mechanisms Underlying the Anti-vascular Endothelial Growth Factor Activity in Tumors

Effect of intravitreal VEGF inhibitors on renal-related adverse events in patients with diabetes mellitus: systematic review and meta-analysis

Evaluation of cardiovascular toxicity of the atezolizumab and bevacizumab combination

Osimertinib Rechallenge With Bevacizumab vs. Chemotherapy Plus Bevacizumab in EGFR-Mutant NSCLC Patients With Osimertinib Resistance

Comprehensive analysis of VEGF/VEGFR inhibitor-induced immune-mediated hypertension: integrating pharmacovigilance, clinical data, and preclinical models

Intravitreal Anti-VEGF Drugs and Signals of Dementia and Parkinson-Like Events: Analysis of the VigiBase Database of Spontaneous Reports